FDA: Recalled hemodialysis catheters could cause serious injury

Aug 01, 2022 - 03:53 PM
FDA Update 900x400

Covidien LLC (Medtronic) recently recalled more than 1 million Palindrome and Mahurkar Hemodialysis Catheters due to a defect that could cause serious injury or death, the Food and Drug Administration announced July 28, identifying it as a Class 1 recall. One complaint but no injuries or deaths have been reported. The company last month recommended customers immediately quarantine and stop using the catheters.
 

Related News Articles

Headline
FDA issues early alerts for certain Baxter, Abiomed products
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
FDA approves first semiannual HIV prevention drug
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences announced June 18. The company…
Headline
White House announces tariffs on goods imported from Canada, Mexico, China
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
FDA evaluating certain plastic syringes made in China
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…
Headline
FDA announces Class I ventilator recall for Draeger product’s pediatric use
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…
Headline
Pfizer issues update on sterile injectables plant struck by tornado
Crews are working to restore power and assess damage to a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals after a tornado…